清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening.

化学 计算生物学 TLR4型 吞吐量
作者
Yue Guan,Katherine Omueti-Ayoade,Sarita K. Mutha,Paul J. Hergenrother,Richard I. Tapping
出处
期刊:Journal of Biological Chemistry [Elsevier BV]
卷期号:285 (31): 23755-23762 被引量:48
标识
DOI:10.1074/jbc.m110.116046
摘要

Toll-like receptors (TLRs) play a central role in host defense by inducing inflammatory and adaptive immune responses following infection. Drugs that target TLRs are of considerable interest as potential inflammatory regulators, vaccine adjuvants, and novel immunotherapeutics. TLR2, in cooperation with either TLR1 or TLR6, mediates responses to a wide variety of microbial products as well as products of host tissue damage. In an effort to understand the structural basis of TLR2 recognition and uncover novel TLR2 agonists, a synthetic chemical library of 24,000 compounds was screened using an IL-8-driven luciferase reporter in cells expressing these human receptors. The screening yielded several novel TLR2-dependent activators that utilize TLR1, TLR6, or both as co-receptors. These novel small molecule compounds are aromatic in nature and structurally unrelated to any known TLR2 agonists. The three most potent compounds do not exhibit synergistic activity, nor do they act as pseudoantagonists toward natural TLR2 activators. Interestingly, two of the compounds exhibit species specificity and are inactive toward murine peritoneal macrophages. Mutational analysis reveals that although the central extracellular region of TLR1 is required for stimulation, there are subtle differences in the mechanism of stimulation mediated by the synthetic compounds in comparison with natural lipoprotein agonists. The three most potent compounds activate cells in the nanomolar range and stimulate cytokine production from human peripheral blood monocytes. Our results confirm the utility of high throughput screens to uncover novel synthetic TLR2 agonists that may be of therapeutic benefit.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
情怀的应助被369ninja采纳,获得10
3秒前
大气翠风完成签到,获得积分10
8秒前
14秒前
Perse发布了新的文献求助10
20秒前
orixero的应助被369ninja采纳,获得10
23秒前
24秒前
香蕉乐曲完成签到,获得积分10
45秒前
48秒前
美好的飞兰完成签到,获得积分10
56秒前
爆米花的应助被369ninja采纳,获得10
57秒前
1分钟前
JUN完成签到,获得积分10
1分钟前
瞿人雄完成签到,获得积分10
1分钟前
没心没肺完成签到,获得积分10
1分钟前
Jasper的应助被科研通管家采纳,获得10
1分钟前
1分钟前
丘比特的应助被科研通管家采纳,获得10
1分钟前
上官若男的应助被科研通管家采纳,获得10
1分钟前
Ava的应助被科研通管家采纳,获得10
1分钟前
大意的之柔完成签到,获得积分10
1分钟前
1分钟前
1分钟前
369ninja发布了新的文献求助10
1分钟前
可靠往事完成签到,获得积分10
1分钟前
自由的梦山完成签到,获得积分10
1分钟前
喜悦如萱完成签到,获得积分10
2分钟前
2分钟前
2分钟前
369ninja发布了新的文献求助10
2分钟前
2分钟前
学霸业的应助被369ninja采纳,获得10
2分钟前
369ninja发布了新的文献求助10
2分钟前
2分钟前
43tg完成签到,获得积分10
2分钟前
qfhbg完成签到,获得积分10
2分钟前
落后哈密瓜完成签到,获得积分10
2分钟前
wetg完成签到,获得积分10
3分钟前
学霸业的应助被369ninja采纳,获得10
3分钟前
portik完成签到,获得积分10
3分钟前
要减肥的菀完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179961
求助须知:如何正确求助?哪些是违规求助? 9570183
关于积分的说明 21808480
捐赠科研通 7775832
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557373
邀请新用户注册赠送积分活动 2478958